2m 2m 2m 2m 2m 2m 2m
BETA BIONICS (BBNX)
NASDAQ
$18.95+$0.08 (+0.42%)
Price as of Oct 02, 2026 4:15 PM EDT- $1.0BMarket Cap
- -7.91%1-Year Change
- Medical DevicesIndustry
BETA BIONICS (BBNX)
$18.95+$0.08 (+0.42%)
BBNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.87 | ||
Change | -$0.11 (-0.58%) | ||
Open | $19.35 | ||
High | $19.44 | ||
Low | $18.39 | ||
Previous Close | $18.98 | ||
Volume | 1,138,106 | ||
30-Day Average Volume | 1,553,868 | ||
1-Week Change | -13.28% | ||
1-Month Change | -1.05% | ||
1-Year Change | -7.91% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 53.9M | ||
Total Assets | $292.4M | ||
Market Cap | $1.0B | ||
Enterprise Value | $973.6M | ||
Period: QTR TTM FY | |||
Revenue | $32.0M | ||
Net Income | -$23.4M | ||
Free Cash Flow | -$15.7M | ||
EBIT | -$23.4M | ||
EBITDA | -$22.7M | ||
Net Working Capital | $205.0M | ||
EPS | -$0.53 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | 30 | ||
P/B | 4 | ||
P/E | -36 | ||
PEG | 4 | ||
Price/Free Cash Flow | -65 | ||
Price/Operating Cash Flow | -70 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue